JT09: Diuretic Activity and Clinical Chemistry in Sprague-Dawley Rats

A study report by Tyler Beck details the diuretic activity of a novel peptide-derived kappa opioid agonist. The data likely contains clinical chemistry and arginine vasopressin release measurements from Sprague-Dawley rats administered various doses of the experimental compound JT09 versus controls. The dataset is shared via the paperswithcode platform under an Open Access license.

Use Cases

• Modeling dose-response relationships for diuretic activity based on administered compound doses.
• Analyzing correlations between experimental compound administration and clinical chemistry markers.
• Studying the effect of a kappa opioid agonist on arginine vasopressin release levels.
• Comparing physiological outcomes between treatment groups and control groups in preclinical research.

Strengths

• Dataset originates from a defined preclinical study with a specific experimental compound (JT09).
• Focuses on measurable endpoints: clinical chemistry and hormone (arginine vasopressin) release.
• Data is associated with a research author and shared under an Open Access license.

Limitations

• Row count and dataset scale are unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Tyler Beck via paperswithcode

Collection Method

Data originates from a controlled animal (rat) study, likely an experimental laboratory procedure.